Annual Accounts Receivable:
$87.86M-$26.97M(-23.49%)Summary
- As of today, TXG annual accounts receivable is $87.86 million, with the most recent change of -$26.97 million (-23.49%) on December 31, 2024.
- During the last 3 years, TXG annual accounts receivable has risen by +$2.61 million (+3.06%).
- TXG annual accounts receivable is now -23.49% below its all-time high of $114.83 million, reached on December 31, 2023.
Performance
TXG Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Receivable:
$43.78M-$6.20M(-12.40%)Summary
- As of today, TXG quarterly accounts receivable is $43.78 million, with the most recent change of -$6.20 million (-12.40%) on September 30, 2025.
- Over the past year, TXG quarterly accounts receivable has dropped by -$39.75 million (-47.59%).
- TXG quarterly accounts receivable is now -90.89% below its all-time high of $480.74 million, reached on March 1, 2016.
Performance
TXG Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TXG Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -23.5% | -47.6% |
| 3Y3 Years | +3.1% | -47.6% |
| 5Y5 Years | +163.3% | +21.5% |
TXG Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -23.5% | +3.1% | -61.9% | at low |
| 5Y | 5-Year | -23.5% | +163.3% | -61.9% | +21.5% |
| All-Time | All-Time | -23.5% | +558.6% | -90.9% | +228.2% |
TXG Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $43.78M(-12.4%) |
| Jun 2025 | - | $49.98M(-4.9%) |
| Mar 2025 | - | $52.55M(-40.2%) |
| Dec 2024 | $87.86M(-23.5%) | $87.86M(+5.2%) |
| Sep 2024 | - | $83.53M(-8.4%) |
| Jun 2024 | - | $91.18M(-0.1%) |
| Mar 2024 | - | $91.31M(-20.5%) |
| Dec 2023 | $114.83M(+10.2%) | $114.83M(+10.6%) |
| Sep 2023 | - | $103.85M(+18.4%) |
| Jun 2023 | - | $87.69M(+12.5%) |
| Mar 2023 | - | $77.94M(-25.2%) |
| Dec 2022 | $104.21M(+22.2%) | $104.21M(+24.7%) |
| Sep 2022 | - | $83.55M(+9.6%) |
| Jun 2022 | - | $76.20M(-0.4%) |
| Mar 2022 | - | $76.53M(-10.2%) |
| Dec 2021 | $85.25M(+66.5%) | $85.25M(+8.7%) |
| Sep 2021 | - | $78.43M(+31.4%) |
| Jun 2021 | - | $59.68M(+4.0%) |
| Mar 2021 | - | $57.41M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $51.21M(+53.5%) | $51.21M(+42.1%) |
| Sep 2020 | - | $36.03M(+58.5%) |
| Jun 2020 | - | $22.73M(-26.3%) |
| Mar 2020 | - | $30.85M(-7.6%) |
| Dec 2019 | $33.37M(+18.8%) | $33.37M(+27.6%) |
| Sep 2019 | - | $26.15M(-2.4%) |
| Jun 2019 | - | $26.80M(-4.6%) |
| Dec 2018 | $28.09M(+110.5%) | $28.09M(+110.5%) |
| Dec 2017 | $13.34M | - |
| Dec 2017 | - | $13.34M(-97.2%) |
| Sep 2017 | - | $480.03M(+2.1%) |
| Jun 2017 | - | $470.13M(-2.1%) |
| Mar 2017 | - | $480.17M(+7.0%) |
| Dec 2016 | - | $448.58M(+5.8%) |
| Sep 2016 | - | $424.00M(-0.7%) |
| Jun 2016 | - | $427.06M(-11.2%) |
| Mar 2016 | - | $480.74M(+2.3%) |
| Dec 2015 | - | $470.12M(+24.2%) |
| Sep 2015 | - | $378.41M(-12.8%) |
| Mar 2015 | - | $433.74M |
FAQ
- What is 10x Genomics, Inc. annual accounts receivable?
- What is the all-time high annual accounts receivable for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. annual accounts receivable year-on-year change?
- What is 10x Genomics, Inc. quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. quarterly accounts receivable year-on-year change?
What is 10x Genomics, Inc. annual accounts receivable?
The current annual accounts receivable of TXG is $87.86M
What is the all-time high annual accounts receivable for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high annual accounts receivable is $114.83M
What is 10x Genomics, Inc. annual accounts receivable year-on-year change?
Over the past year, TXG annual accounts receivable has changed by -$26.97M (-23.49%)
What is 10x Genomics, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of TXG is $43.78M
What is the all-time high quarterly accounts receivable for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high quarterly accounts receivable is $480.74M
What is 10x Genomics, Inc. quarterly accounts receivable year-on-year change?
Over the past year, TXG quarterly accounts receivable has changed by -$39.75M (-47.59%)